Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...
Analysts have recently evaluated Abbott Laboratories and provided 12-month price targets. The average target is $145.12, ...
Abbott Laboratories (NYSE:ABT) recently experienced a 20% price increase over the last quarter. This uptick coincides with several noteworthy developments, including Abbott's collaboration with ...
The stock's fall snapped a two-day winning streak.
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a ...
Abbott Laboratories (ABT) sees mixed momentum as shares dip after gains. Analysts highlight strong demand, low debt, and ...
Abbott Laboratories' (NYSE:ABT) stock is up by a considerable 21% over the past three months. Since the market ...
Highlights,Abbott Laboratories has experienced a significant increase in stock value over recent months.,The company's return ...
Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops & manufactures a diversified line of healthcare ...
Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops & manufactures a diversified line of healthcare products. Valued at $239.4 billion by market cap, Abbott’s extensive ...